Rafael
Coveñas Rodríguez
Profesor Titular de Universidad


Universitat de Barcelona
Barcelona, EspañaPublications in collaboration with researchers from Universitat de Barcelona (1)
2014
-
The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer
International Journal of Oncology, Vol. 45, Núm. 4, pp. 1658-1672